Press Releases

Lancaster General Health Receives First Commercial InCise™ Multileaf Collimator for the CyberKnife® M6™ System

SUNNYVALE, Calif., and LANCASTER, PA, February 24, 2015 -- Accuray Incorporated (Nasdaq: ARAY) and Lancaster General Health announced today that the first commercially available InCise™ Multileaf Collimator (MLC) for the CyberKnife® M6™ System has been received by Lancaster. The hospital selected the InCise MLC based on its ability to increase the system’s treatment efficiency and extend its unique capabilities to a broader range of patient cases.

Read More »
Class A User Licenses for Accuray Products Awarded to 16 Hospitals in China SUNNYVALE, Calif., February 17, 2015 -- Accuray Incorporated (Nasdaq: ARAY) announced that class A user licenses for Accuray products were awarded to 16 hospitals during February by the Chinese National Health and Family Planning Commission (NHFPC). TomoTherapy® System licenses were received by 12 hospitals and CyberKnife® System licenses were received by four hospitals Read More »
Accuray to Participate in the Cowen 35th Annual Healthcare Conference SUNNYVALE, Calif., Feb. 9, 2015 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to present at the Cowen 35th Annual Healthcare Conference in Boston on Monday, March 2, 2015 at 2:10pm ET. A live webcast of the presentation will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days. Read More »
First TomoTherapy® System in Latin America Dedicated Solely to Breast Cancer Care Now Treating Patients SUNNYVALE, Calif., February 4, 2015 – Accuray Incorporated (Nasdaq: ARAY) announced today that the first TomoTherapy® System in Latin America dedicated solely to the treatment of breast cancer is now operational at FUCAM (Fundacion de Cancer de Mama) in Mexico City. More than 120 women have been treated with the innovative radiation therapy technology since the center began using it over two months ago. FUCAM’s decision to install the TomoTherapy System reinforces growing medical community support for its use as a mainstream treatment to improve tumor control with reduced toxicities. Read More »
60% of the French Population Feel Uninformed About Cancer Treatment Options According to the New Accuray / IFOP Survey SUNNYVALE, Calif., January 28, 2015 - Accuray Incorporated (Nasdaq: ARAY) announced results of a survey of 1,000 French consumers which reveal that while respondents have a basic level of knowledge on cancer care options, 60 percent believe they do not have enough information to have a personal opinion on treatments.1 Overall, the survey indicates more education may be needed to enable people to make an informed decision if faced with a cancer diagnosis. Read More »
Accuray Reports Financial Results for Second Quarter of Fiscal Year 2015 SUNNYVALE, Calif., January 27, 2015 – Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the second fiscal quarter and six months ended December 31, 2014. Read More »
Accuray to Report Results for Second Quarter Fiscal 2015 on January 27, 2015 SUNNYVALE, CALIF., January 12, 2015—Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2014 on January 27, 2015 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day. Read More »
Centre Hospitalier Regional Universitaire (CHRU) in Tours Now Treating Patients with the TomoTherapy® System SUNNYVALE, Calif., January 9, 2015 – Accuray Incorporated (Nasdaq: ARAY) announced today that CHRU Tours is now treating cancer patients with the TomoTherapy® System. Read More »

Pages